CDDO-EA
CAS: 932730-51-3
Ref. 3D-HMB73051
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Product Information
CDDO-EA is a synthetic compound that is being studied for its potential as an anti-cancer therapy. This agent has shown to have growth factor-β1 response elements and can be used as an experimental model for proton irradiation. CDDO-EA has been shown to work by inhibiting the production of reactive oxygen species that are produced in response to oxidative injury, which may lead to cancer. CDDO-EA also promotes the development of the M2 phenotype, which suppresses tumor growth and causes myeloid-derived suppressors (MDS) cells to develop in a tumor microenvironment. These cells produce cytokines that promote an anti-tumor immune response.
Chemical properties
Technical inquiry about: 3D-HMB73051 CDDO-EA
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
